Annual Accounts Payable
$1.40 M
-$458.80 K-24.65%
December 31, 2023
Summary
- As of February 7, 2025, BGLC annual accounts payable is $1.40 million, with the most recent change of -$458.80 thousand (-24.65%) on December 31, 2023.
- During the last 3 years, BGLC annual accounts payable has fallen by -$1.77 million (-55.78%).
- BGLC annual accounts payable is now -55.78% below its all-time high of $3.17 million, reached on December 1, 2020.
Performance
BGLC Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.03 M
+$78.30 K+8.20%
September 30, 2024
Summary
- As of February 7, 2025, BGLC quarterly accounts payable is $1.03 million, with the most recent change of +$78.30 thousand (+8.20%) on September 30, 2024.
- Over the past year, BGLC quarterly accounts payable has increased by +$78.30 thousand (+8.20%).
- BGLC quarterly accounts payable is now -67.42% below its all-time high of $3.17 million, reached on December 1, 2020.
Performance
BGLC Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
BGLC Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.6% | +8.2% |
| 3 y3 years | -55.8% | -30.8% |
| 5 y5 years | - | -30.8% |
BGLC Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.3% | at low | -48.7% | +8.2% |
| 5 y | 5-year | -55.8% | -100.0% | -67.4% | -100.0% |
| alltime | all time | -55.8% | -100.0% | -67.4% | -100.0% |
BioNexus Gene Lab Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.03 M(+8.2%) |
| Jun 2024 | - | $954.80 K(-33.2%) |
| Mar 2024 | - | $1.43 M(+1.9%) |
| Dec 2023 | $1.40 M(-24.7%) | $1.40 M(-10.7%) |
| Sep 2023 | - | $1.57 M(-13.9%) |
| Jun 2023 | - | $1.82 M(+22.0%) |
| Mar 2023 | - | $1.49 M(-19.7%) |
| Dec 2022 | $1.86 M | $1.86 M(+45.5%) |
| Sep 2022 | - | $1.28 M(-9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $1.42 M(-22.8%) |
| Mar 2022 | - | $1.83 M(-8.8%) |
| Dec 2021 | $2.01 M(-36.5%) | - |
| Dec 2021 | - | $2.01 M(-16.6%) |
| Sep 2021 | - | $2.41 M(+0.7%) |
| Jun 2021 | - | $2.39 M(-18.2%) |
| Mar 2021 | - | $2.93 M(-7.6%) |
| Dec 2020 | $3.17 M(>+9900.0%) | $3.17 M(>+9900.0%) |
| Jun 2020 | - | $900.00(>+9900.0%) |
| Dec 2019 | $0.00 | $0.00 |
FAQ
- What is BioNexus Gene Lab annual accounts payable?
- What is the all time high annual accounts payable for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual accounts payable year-on-year change?
- What is BioNexus Gene Lab quarterly accounts payable?
- What is the all time high quarterly accounts payable for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly accounts payable year-on-year change?
What is BioNexus Gene Lab annual accounts payable?
The current annual accounts payable of BGLC is $1.40 M
What is the all time high annual accounts payable for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual accounts payable is $3.17 M
What is BioNexus Gene Lab annual accounts payable year-on-year change?
Over the past year, BGLC annual accounts payable has changed by -$458.80 K (-24.65%)
What is BioNexus Gene Lab quarterly accounts payable?
The current quarterly accounts payable of BGLC is $1.03 M
What is the all time high quarterly accounts payable for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly accounts payable is $3.17 M
What is BioNexus Gene Lab quarterly accounts payable year-on-year change?
Over the past year, BGLC quarterly accounts payable has changed by +$78.30 K (+8.20%)